ODDB.org: Open Drug Database

Swissmedic Registration	67617	Date of registration	13.07.2020
Company name	Roche Pharma (Schweiz) AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.15.	Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Enspryng 120 mg	Injektionslösung zur subkutanen Anwendung	Injektionslösung zur subkutanen Anwendung (Satralizumabum 120 mg/ml)	L04AC19	CI

2025	©ywesee GmbH